国际眼科纵览 ›› 2025, Vol. 49 ›› Issue (4): 297-303.doi: 10. 3760/cma.j.cn115500-20250304-25410

• 综述 • 上一篇    下一篇

黄斑疾病心理影响因素的研究进展

张晋荣1,2 张悦1,3 王佳宁1,3 喻晓兵 1   

  1. 1北京医院眼科 国家老年医学中心 中国医学科学院老年医学研究所,北京 100730;2北京大学第五临床医学院,北京 100730;3中国医学科学院北京协和医学院,北京 100730
  • 收稿日期:2025-03-04 出版日期:2025-08-22 发布日期:2025-08-12
  • 通讯作者: 喻晓兵,Email:yuxiaobing1214@163.com E-mail:yuxiaobing1214@163.com
  • 基金资助:
    中央高水平医院临床科研业务费专项临床研究专项(BJ-2024-089)

Advanced research on psychological impact factors of macular diseases

Zhang Jinrong1,2, Zhang Yue1,3, Wang Jianing1,3, Yu Xiaobing1   

  1. 1Department of Ophthalmology, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100730, China; 2Peking University Fifth School of Clinical Medicine, Beijing 100730, China; 3Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China
  • Received:2025-03-04 Online:2025-08-22 Published:2025-08-12
  • Contact: Yu Xiaobing, Email: yuxiaobing1214@163.com E-mail:yuxiaobing1214@163.com
  • Supported by:
    Clinical Research Program of the Special Fund for Clinical and Scientific Research of High-Level Central Hospitals (BJ-2024-089)

摘要: 黄斑疾病(包括中心性浆液性脉络膜视网膜病变、年龄相关性黄斑变性、糖尿病性黄斑水肿及黄斑裂孔等)除可引发不同程度的视功能损害外,亦与多种心理障碍密切相关,焦虑、抑郁及应激相关障碍在患者中呈现出较高发生率。A型人格、心理压力可能增加中心性浆液性脉络膜视网膜病变的患病风险,并影响疾病进程与复发率,其潜在机制涉及下丘脑-垂体-肾上腺轴功能紊乱、皮质醇及儿茶酚胺水平升高、盐皮质激素受体通路异常激活以及自主神经功能失衡等多种病理过程。在治疗层面,虽然抗血管内皮生长因子疗法治疗年龄相关性黄斑变性在改善视力方面取得积极疗效,但长期重复注射所引发的心理压力与治疗依从性下降也不容忽视。临床观察提示,治疗相关焦虑与抑郁症状对生活质量及视力结局均有潜在影响。临床上应关注心理因素在黄斑疾病管理中的重要性。

关键词: 黄斑疾病, 心理因素

Abstract: Macular diseases, including central serous chorioretinopathy (CSCR), age-related macular degeneration (AMD), diabetic macular edema, and macular hole, could lead to varying degrees of visual impairment and are also closely associated with a range of psychological disorders. Anxiety, depression, and stress-related conditions are found at a higher prevalence among affected individuals. Type A personality traits and elevated psychological stress may increase the risk of CSCR onset and influence its progression and recurrence. The underlying mechanisms are thought to involve dysregulation of the hypothalamic-pituitary-adrenal axis, elevated levels of cortisol and catecholamines, abnormal activation of the mineralocorticoid receptor pathway, and autonomic nervous system dysfunction, among other pathological processes. Therapeutically, while anti-vascular endothelial growth factor (VEGF) therapy has shown significant efficacy in improving visual outcomes in AMD, the psychological burden of repeated intravitreal injections may contribute to increased stress and reduced treatment adherence. Clinical observational studies suggest that treatment-related anxiety and depressive symptoms may adversely affect patients' quality of life and visual prognosis. The critical role of psychological impact factors was highlighted in the management of the macular diseases.

Key words: Macular diseases, Psychological factor